Abstract
Klebsiella pneumoniae is associated with a variety of infections, such as pneumonia, urogenital infection, liver abscess, and bloodstream infection. It is especially dangerous for patients in medical facilities, where it can cause ventilator-associated pneumonia or intensive care unit-acquired pneumonia. The emergence of multidrug-resistant and hypervirulent strains as well as the ability to form biofilms on various medical devices complicates the treatment of such infections and makes the use of antibiotics ineffective. The application of bacteriophages is a promising alternative for combating Klebsiella pneumoniae biofilms. In the present study a cocktail of 3 bacteriophages with depolymerase activity was used to control antibiotic resistant Klebsiella pneumoniae biofilms in vitro. Biofilms were examined using optical and scanning electron microscopy. The obtained results demonstrate that the studied bacteriophage cocktail can effectively disrupt Klebsiella pneumoniae biofilms.
Similar content being viewed by others
Introduction
Klebsiella pneumoniae is a Gram-negative bacterium associated with different human health conditions such as pneumonia, bloodstream infection, urogenital infection, etc. It is one of the most frequently detected bacteria in human respiratory tract infections, especially in healthcare patients, as it is often linked to ventilator-associated pneumonia (VAP) and intensive care unit (ICU)-acquired pneumonia1, which are among the most common bacterial complications following viral respiratory tract infections, including severe acute respiratory syndrome-related coronavirus 2 (Sars-Cov-2)2,3. It has been reported that pan drug resistant (PDR) K. pneumoniae is the most frequently isolated bacteria in critically ill coronavirus disease 2019 (COVID-19) patients under mechanical ventilation4. The treatment of such infections is complicated by increasing levels of resistance to antimicrobial drugs. An increase in the incidence of K. pneumoniae infections caused by carbapenem-resistant strains has been detected worldwide, which has resulted from the use of carbapenem-class antibiotics against extended spectrum β-lactamases (ESBL)-producing strains of K. pneumoniae5,6,7. Global studies show that a significant proportion of nosocomial K. pneumoniae isolates exhibit extended spectrum β-lactamases (ESBLs) and carbapenemases activity8. Some K. pneumoniae isolates are resistant to the most of clinical antimicrobial agents (pan drug resistant), such as aminoglycoside, quinolone, β-lactam antibiotics, polymyxin and tigecycline9,10.
K. pneumoniae strains are able to form biofilms, which are extracellular polymeric structures consisting of deoxyribonucleic acid (DNA), proteins, and polysaccharides. K. pneumoniae biofilm growth includes the adhesion of cells, the development of small clusters, the maturation, and the release of free-living planktonic cells11. Biofilm development on catheters, tubes and other medical equipment increases the risk of acute infections in patients receiving medical care, especially in those on prolonged mechanical life support, because the biofilm matrix not only physically protects the bacterial cells, but also contributes to the transmission of mobile genetic elements, which increases the tolerance of microorganisms to antibiotics12.
The emergence of antibiotic resistance and the reduced possibility of treating the sick patients encourages researchers to pursue novel approaches to regulating bacterial growth and re-establishing the microbiota's natural equilibrium. Bacteriophages are increasingly being used by scientists and clinicians to control antibiotic resistant strains of bacteria13. The use of bacteriophages against antibiotic resistant bacteria has been shown to be successful in limiting bacterial growth, as well as restoring susceptibility to antimicrobial drugs14. The described effects are probably associated with a switch in the adaptation mechanisms of the bacterial population to bacteriophage infection. Furthermore, bacteriophages whose genomes encode exopolysaccharide depolymerases can use exopolysaccharides as primary receptors and cleave polymer bonds until reaching the cell membrane, which contributes to the biofilm degradation and infection of resident bacteria15,16.
The aim of the present study was to test the efficacy of the previously characterized bacteriophages encoding polysaccharide depolymerases against K. pneumoniae biofilms.
Material and methods
Bacteriophages
Bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 that had been previously isolated from sewage waters and fully characterized17 were used in this study.
The selected bacteriophages were tested in vivo as a part of a broader phage cocktails in published studies18,19. Real-time in vitro analysis of K.pneumoniae (Kl 315) culture lysis with a cocktail of selected phages was carried out in a previous study using imaging with a 3D Cell Explorer microscope19.
Bacterial strains
For the bacteriophage efficiency study, the multidrug-resistant clinical strain Kl 315 of K. pneumoniae from the RPC “MicroMir” collection was selected. The strain was obtained from a patient with pneumonia, examined on a MALDI-TOF Microflex mass spectrometer (Bruker, Billerica, MA, USA) and with biochemical tests (MIKROLATEST, Erba Mannheim) with further analysis on Multiskan Ascent spectrophotometer (Thermo Scientific, Waltham, MA, USA) and was tested for antibiotic susceptibility by a disc diffusion test (Kirby Bauer method) for antimicrobials using the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical Laboratories Standards Institute (CLSI) standards before adding to collection. Antibiotic susceptibility test results are presented in Supplementary Table S1. The same strain was chosen to examine the properties of the bacteriophages used in this study17.
Biofilm formation
For biofilm formation, 18-h cultures of Kl 315 strain grown on Brain Heart Infusion (BHI) agar (Himedia, India) were used. Suspension of bacteria at a concentration of 1 × 105 CFU/ml in a volume of 5 ml was shaken on a Vortex mixer (Misrospin FV-2400, Biosan, Latvia) and added to Petri dishes with 20 ml of BHI broth (Himedia, India). Sterile glass slides were placed on the bottom of Petri dishes, then sterile degreased coverslips were placed on top of the slides and incubated in the thermostat (Binder GmbH, Germany) for 24–72 h at 37 °C.
Biofilm infection with bacteriophages
After 24 h of Kl 315 biofilm formation, 0.1 ml of bacteriophage cocktail with a concentration of 1 × 107 PFU/ml of each phage (vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14) or a single phage vB_KpnP_FZ12 was added and incubated in the thermostat (Binder GmbH, Germany) for 24–48 h at 37 °C. Control glass slides with glass coverslips were incubated without bacteriophage addition.
Biofilm fixation
For optical microscope visualization, coverslips were removed with tweezers and placed into Petri dishes with paper filters at the bottom without drying. To preserve the natural form of biofilms, samples were vapor-fixed with 25% glutaric aldehyde for 3 h. After fixation, the samples were stained with DAPI (Sigma-Aldrich, Germany). The effect of bacteriophage cocktail on biofilm formation and destruction was evaluated using an AxioImager A1 light microscope (Carl Zeiss, Germany).
For scanning electron microscopy (SEM), samples were fixed with 2.5% glutaraldehyde for 60 min, then dehydrated in a graded ethanol series (30, 50, 70, 80, and 96%) and placed into acetone. The samples were dried in a critical-point dryer HCP-2 (Hitachi Ltd., Japan) and coated with Au–Pd in IB-3 ion coater (Eiko Engineering Co., Tokyo, Japan). Samples were visualized in Camscan-S2 (Cambridge, United Kingdom) scanning electron microscope.
Results
Bacteriophages
In a previous study17, the morphology of the bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 was evaluated by transmission electron microscopy, thermal and pH stability were assessed, one-step growth parameters, host adsorption rate, host range and phage resistant form generation frequency were characterized, and full genome sequencing and analysis were performed. All 3 bacteriophages encode polysaccharide depolymerases and form plaques with halo. A cocktail of 3 phages was selected for further in vitro and in vivo studies, as the evaluation of lytic spectra and the frequency of generation of phage-resistant forms showed that the use of the selected phage cocktail not only increases the lytic efficacy of the preparation, but also significantly reduces the risk of formation of phage-resistant forms. The tail fiber proteins of all 3 phages differed in their folding and domain structure, as was found by analyzing homologues of structural proteins from the UniProt database (vB_KpnS_FZ10–A0A4D6T3L6; vB_KpnP_FZ12–A0A4D6T3P7; vB_KpnM_FZ14–A0A4D8SZG4; vB_KpnS_FZ41–A0A4D6T3Y8). Tail proteins of bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 were shown to share homology to phage proteins with known endosialidase, peptidoglycan hydrolase, and hyaluronate lyase domains, respectively, all of which have been confirmed to have polysaccharide degrading activity. The titers obtained by growing the phages in liquid nutrient medium showed that they could effectively inhibit the growth of K. pneumoniae culture and indicated sufficient virus productivity to obtain high concentrations in the final preparation. A real-time in vitro phage lysis assay showed that the selected phage cocktail could effectively lyse Kl 315 planktonic cells of K. pneumoniae culture and disrupt small microcolonies adhered on the glass surface19. Therefore, the cocktail of bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 was chosen for further studies on more mature biofilms carried out in the present work and vB_KpnP_FZ12 was selected as the most productive on Kl 315 strain to compare the efficacy of a single phage vs three-phage cocktail on K. pneumoniae biofilms.
Optical microscope biofilm imaging
After 24 h of Kl 315 biofilm formation, a single phage vB_KpnP_FZ12 or a cocktail of bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 was added to the biofilm and incubated for additional 24 h. Control glasses were incubated for 48 and 72 h without the addition of bacteriophages. After 48 h of incubation the formation of chains and clusters was observed in control glasses, which is common for biofilms of all bacterial species, while only single cells and small colonies were observed on the experimental glasses with the addition of phages (Fig. 1). The antibiofilm activity of the phage cocktail was similar to that of single vB_KpnP_FZ12.
After 72 h of incubation, a mature biofilm with water channels was formed on control glass slides (Fig. 2A,D,G). Only single cells and small colonies were observed on the experimental glasses with the addition of single vB_KpnP_FZ12 (Fig. 2B,E,H) or three-phage cocktail (Fig. 2C,F,I). The antibiofilm activity of the phage cocktail was similar to that of single vB_KpnP_FZ12.
Scanning electron microscope biofilm imaging
After 24 h of incubation (biofilm formation by Kl 315), small microcolonies and formed filaments were observed on the coverslips incubated without bacteriophage cocktail (Fig. 3A). After incubation for additional 24 h the formation of biofilm with clusters and channels was observed in culture without bacteriophage cocktail (Fig. 3B,C). Incubation for 72 h resulted in the formation of a mature biofilm on the surface of coverslips (Fig. 3E). In samples treated by the bacteriophage cocktail after incubation for 24 h and subsequent incubation for 24 and 48 h, only individual bacterial cells and small aggregates were observed (Fig. 3D,F).
The results of application of a single vB_KpnP_FZ12 bacteriophage were comparable to those of the bacteriophage cocktail. In samples treated with vB_KpnP_FZ12 alone after incubation for 24 h and subsequent incubations for 24 and 48 h, only single bacterial cells and small aggregates were also observed (Fig. 4A,B).
Discussion
The previous studies have described various effects of biofilm treatment with bacteriophages. Phage 117 with unconfirmed depolymerase activity (the authors only hypothesized the presence of depolymerases based on the halo obtained on Petri dishes) had no significant effect on biofilm formation when added at the same time as the bacterial culture at MOI of 0.120. Other researchers studied the vB_KpnS_Kp13 phage, which effectively destroyed pre-formed 24 h biofilms in an MOI and time-dependent manner. After 2 h incubation at MOI 10, a loss of 51.8% of biomass was detected. Further, the biomass reduction increased to 54.2%, 57.5% and 72.9% after 12, 24 and 48 h, respectively. These values also decreased at phage-to-bacteria ratios of 1:1 (MOI 1) and 1:10 (MOI 0.1), but still resulted in marked biofilm degradation21. The results of its genome analysis showed that the indicated activity was associated with an ORF2-encoded capsule depolymerase. In a study of TSK1 bacteriophage with depolymerase activity researchers compared pre-treatment and post-treatment of biofilms with a single phage. In the pre-treatment experiment TSK1 was added along with the bacterial culture at an MOI of 0.6 and incubated the plate at 37 ± 1 °C for 72 h. In post-treatment experiments, K. pneumoniae biofilm of different ages (1–3 days old) was exposed to bacteriophage at 0.6 MOI. It was shown that post-treatment of K. pneumoniae biofilms of different ages reduced biomass by 85–100%. Pre-treatment of K. pneumoniae biofilms with bacteriophage TSK1 reduced > 99% biomass in the first 24 h of incubation. The biofilm removal tendency was not different for biofilms of different ages as the difference in biomass reduction was not statistically significant22. In all conducted experiments, complete eradication of the bacterial culture was not achieved, but a significant decrease in titers and biofilm destruction was observed. However, combined phage-antibiotic therapy may be a solution for complete eradication of bacterial colonization when necessary. A combination of a pre-adapted bacteriophage and antibiotic is known to be used in the treatment of a patient with fracture-related pandrug-resistant K. pneumoniae infection23. The combination was highly effective in vitro, in 7-day mature biofilms and in suspensions. The researchers observed that ceftazidime/avibactam dose- and time-dependently reduced the number of K. pneumoniae bacteria in mature biofilms, but without total elimination. High doses of phage also did not destroy the bacteria in such mature biofilms. However, combinations of high doses of pre-adapted phage M1 and moderate concentrations of ceftazidime/avibactam were significantly more effective than the antibiotic alone. The patient's therapy resulted in objective clinical, microbiological and radiological improvement of the wounds and general condition. In many studies of the effects of bacteriophages on biofilms, no difference in efficacy is observed between the use of a single phage and a cocktail of bacteriophages. For example, a study of the phages 39APmC32, 65APm2833 and 72APm5211 showed that the antibiofilm activity of phage cocktails on 24 h Proteus mirabilis biofilms was similar than that of the most active phage24. In another study, the pretreatment of 48 h-old biofilm with the Pseudomonas aeruginosa phage cocktail resulted in a titer reduction of the same order of magnitude as with a single phage application. However, researchers reported that the application of the phage cocktail rather than single phages prevented the appearance of phage-resistant bacteria25. Thus, in the present study we decided to perform a comparison of the efficacy of single phage and phage cocktail in biofilm disruption. The present study demonstrated the ability of both single phage and three-phage cocktail with depolymerase activity to effectively control antibiotic resistant K. pneumoniae biofilms. In control of the experiment, all stages of biofilm formation were observed, from single adherent cells, formation of small colonies, clusters, and to biofilm formation and maturation. It is noteworthy that filament formation by K. pneumoniae cells was observed in the present study. The production of filaments has been associated with the process of biofilm formation and modern research indicates that filamentation plays a vital role in biofilm development26. There is also evidence that exposure to beta-lactam antibiotics is associated with an increased frequency of filament formation27, it has been reported that K. pneumoniae cells could form filaments in response to cefotiam and cefazolin28. We hypothesize that since the biofilm is composed of heterogeneous cells with different metabolism, which plays a key role in adaptation29,30, it is possible that exposure to antibiotics leads to the selection of filamentous cells that are already presented in the population.
Bacteriophages were added after 24 h of biofilm development, when such stages of biofilm growth as microcolony and filament formation were observed in the control samples. These time points were chosen based on previous studies21,22 and to monitor the effect of bacteriophages on the transition to more mature stages of biofilm formation, as the cocktail could be potentially used in the treatment of different medical devices (including catheters and ventilator tubes) to prevent biofilm formation on them. The addition of bacteriophages to the cell culture prevented biofilm formation; only single cells and small microcolonies were observed in the samples with phages. Application of vB_KpnP_FZ12 phage alone showed the same efficacy in inhibiting biofilm growth as the application of a bacteriophage cocktail composed of three phages (vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14). Complete lysis was not observed, but we presume that this is extremely difficult to achieve with bacteriophage treatment, since even between lytic phages and bacteria more complex mechanisms that regulate lysis exist, such as quorum sensing, hibernation or transient resistance31,32,33. Researchers also observed inherently susceptible but phenotypically antibiotic-resistant subpopulations of bacteria34, the presence of persisters in the bacterial population can potentially influence phage infection as well. However, the obtained results show the potential of the selected phage cocktail in the early-stage treatment of different medical devices to prevent biofilm formation on them. Moreover, complete elimination may often not be necessary even in the medical treatment since in humans Klebsiella spp. can be found as commensals of the gastrointestinal tract, mouth, and nasopharynx35, thus a significant reduction in titers, biofilm disruption, and restoration of normal microbiota balance can become clinically significant. The combined phage-antibiotic therapy could be a solution for the complete eradication of biofilms and bacterial colonization in those cases where it is necessary23,36.
The present study shows the potential of the selected bacteriophages in controlling K. pneumoniae biofilms. Despite the demonstrated similar efficacy of the single phage and the bacteriophage cocktail in biofilm disruption, phage cocktails are recommended in therapy to prevent phage resistance as well as to improve lytic effects by expanding the phage-host range and increasing the number of target pathogens37. We will pursue further studies on the efficacy of bacteriophages vB_KpnS_FZ10, vB_KpnP_FZ12, vB_KpnM_FZ14 in the control of biofilms associated with medical devices and their possible in vivo application to control K. pneumoniae biofilm-associated infections.
Data availability
The complete genome sequences of Klebsiella pneumoniae phages vB_KpnS_FZ10, vB_KpnP_FZ12 and vB_KpnM_FZ14 have been deposited in GenBank under the accession numbers MK521904, MK521905 and MK521906, respectively. Raw Illumina reads are available on NCBI SRA under accession numbers SRR10037530, SRR10037529 and SRR10037528, respectively. The associated BioProject accession number is RJNA562287.
References
Zhang, Y. et al. Disease burden of intensive care unit-acquired pneumonia in China: A systematic review and meta-analysis. Int. J. Infect. Dis. 29, 84–90 (2014).
Zhu, X. et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 285, 198005. https://doi.org/10.1016/j.virusres.2020.198005 (2020).
Mirzaei, R. et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life 72, 2097–2111. https://doi.org/10.1002/iub.2356 (2020).
Meawed, T. E., Ahmed, S. M., Mowafy, S. M. S., Samir, G. M. & Anis, R. H. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. J. Infect. Public Health. 14(10), 1375–1380. https://doi.org/10.1016/j.jiph.2021.08.003 (2021).
Chong, Y., Yakushiji, H., Ito, Y. & Kamimura, T. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur. J. Clin. Microbiol. Infect. Dis. 30(1), 83–87. https://doi.org/10.1007/s10096-010-1057-1 (2011).
Munoz-Price, L. S. et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect. Dis. 13, 785–796. https://doi.org/10.1016/S1473-3099(13)70190-7 (2013).
David, S. et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat. Microbiol. 4, 1919–1929 (2019).
Pitout, J. D., Nordmann, P. & Poirel, L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob. Agents Chemother. 59, 5873–5884. https://doi.org/10.1128/AAC.01019-15 (2015).
Wang, G., Zhao, G., Chao, X., Xie, L. & Wang, H. The characteristic of virulence, biofilm and antibiotic resistance of Klebsiella pneumoniae. Int. J. Environ. Res. Public Health. 17(17), 6278. https://doi.org/10.3390/ijerph17176278 (2020).
Lv, F. et al. Overexpression of efflux pumps mediate pan resistance of Klebsiella pneumoniae sequence type 11. Microb. Drug Resist. 27(10), 1405–1411. https://doi.org/10.1089/mdr.2020.0395 (2021).
Guerra, M. E. S. et al. Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Front. Cell Infect. Microbiol. 12, 877995. https://doi.org/10.3389/fcimb.2022.877995 (2022).
Ribeiro, S. M., Cardoso, M. H., Candido Ede, S. & Franco, O. L. Understanding, preventing and eradicating Klebsiella pneumoniae biofilms. Future Microbiol. 11, 527–538. https://doi.org/10.2217/fmb.16.7 (2016).
Brives, C. & Pourraz, J. Phage therapy as a potential solution in the fight against AMR: Obstacles and possible futures. Palgrave Commun. 6, 100. https://doi.org/10.1057/s41599-020-0478-4 (2020).
Chan, B. K. et al. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci. Rep. 6, 26717. https://doi.org/10.1038/srep26717 (2016).
Yan, J., Mao, J. & Xie, J. Bacteriophage polysaccharide depolymerases and biomedical applications. BioDrugs 28, 265–274. https://doi.org/10.1007/s40259-013-0081-y (2014).
Leiman, P. G. et al. The structures of bacteriophages K1E and K1–5 explain processive degradation of polysaccharide capsules and evolution of new host specificities. J. Mol. Biol. 371, 836–849 (2007).
Zurabov, F. & Zhilenkov, E. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Virol. J. 18, 9. https://doi.org/10.1186/s12985-020-01485-w (2021).
Beloborodova, N. et al. Adaptive phage therapy in the treatment of patients with recurrent pneumonia (pilot study). Obs. Reanimatol. 17, 4–14. https://doi.org/10.15360/1813-9779-2021-6-4-14 (2021).
Zurabov, F. M. et al. Bacteriophage cocktails in the post-COVID rehabilitation. Viruses 14, 2614. https://doi.org/10.3390/v14122614 (2022).
Tan, D. et al. Characterization of Klebsiella pneumoniae ST11 isolates and their interactions with lytic phages. Viruses 11(11), 1080. https://doi.org/10.3390/v11111080 (2019).
Horváth, M. et al. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates. Sci. Rep. 10(1), 5891. https://doi.org/10.1038/s41598-020-62691-8 (2020).
Tabassum, R. et al. Complete genome analysis of a Siphoviridae phage TSK1 showing biofilm removal potential against Klebsiella pneumoniae. Sci. Rep. 8(1), 17904. https://doi.org/10.1038/s41598-018-36229-y (2018).
Eskenazi, A. et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat. Commun. 13(1), 302. https://doi.org/10.1038/s41467-021-27656-z (2022).
Maszewska, A., Zygmunt, M., Grzejdziak, I. & Różalski, A. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections. J. Appl. Microbiol. 125(5), 1253–1265. https://doi.org/10.1111/jam.14026 (2018).
Fu, W. et al. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54(1), 397–404. https://doi.org/10.1128/AAC.00669-09 (2010).
Anbumani, S. et al. Controlled spatial organization of bacterial growth reveals key role of cell filamentation preceding Xylella fastidiosa biofilm formation. NPJ Biofilms Microb. 7(1), 86. https://doi.org/10.1038/s41522-021-00258-9 (2021).
Buijs, J., Dofferhoff, A. S., Mouton, J. W., Wagenvoort, J. H. & van der Meer, J. W. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria. Clin. Microbiol. Infect. 14(4), 344–349. https://doi.org/10.1111/j.1469-0691.2007.01940.x (2008).
Nakao, M., Nishi, T. & Tsuchiya, K. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin. Antimicrob. Agents Chemother. 19(5), 901–910. https://doi.org/10.1128/AAC.19.5.901 (1981).
Stoodley, P., Sauer, K., Davies, D. G. & Costerton, J. W. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56, 187–209. https://doi.org/10.1146/annurev.micro.56.012302.160705 (2002).
Nadell, C. D., Drescher, K. & Foster, K. R. Spatial structure, cooperation and competition in biofilms. Nat. Rev. Microbiol. 14(9), 589–600. https://doi.org/10.1038/nrmicro.2016.84 (2016).
Silpe, J. E. & Bassler, B. L. A host-produced quorum-sensing autoinducer controls a phage lysis-lysogeny secision. Cell 176(1–2), 268–280. https://doi.org/10.1016/j.cell.2018.10.059 (2019).
Bryan, D., El-Shibiny, A., Hobbs, Z., Porter, J. & Kutter, E. M. Bacteriophage T4 infection of stationary phase E. coli: Life after log from a phage perspective. Front. Microbiol. 7, 1391. https://doi.org/10.3389/fmicb.2016.01391 (2016).
Obradović, M. et al. Isolation, characterization, genome analysis and host resistance development of two novel Lastavirus phages active against pandrug-resistant Klebsiella pneumoniae. Viruses 15(3), 628. https://doi.org/10.3390/v15030628 (2023).
Johnson, P. J. & Levin, B. R. Pharmacodynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 9(1), e1003123. https://doi.org/10.1371/journal.pgen.1003123 (2013).
Gonzalez-Ferrer, S. et al. Finding order in the chaos: Outstanding questions in Klebsiella pneumoniae pathogenesis. Infect. Immun. 89(4), e00693-e720. https://doi.org/10.1128/IAI.00693-20 (2021).
Diallo, K. & Dublanchet, A. Benefits of combined phage-antibiotic therapy for the control of antibiotic-resistant bacteria: A literature review. Antibiotics. 11(7), 839. https://doi.org/10.3390/antibiotics11070839 (2022).
Oechslin, F. Resistance development to bacteriophages occurring during bacteriophage therapy. Viruses 10(7), 351. https://doi.org/10.3390/v10070351 (2018).
Acknowledgements
We would like to thank Bogdanov A.G. and Evtushenko E.A. for their help in operating the scanning electron microscope.
Author information
Authors and Affiliations
Contributions
Writing and visualization, F.Z.; investigation, F.Z., E.G., T.K., V.U.; electron microscope imaging, F.Z.; supervision, V.P. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zurabov, F., Glazunov, E., Kochetova, T. et al. Bacteriophages with depolymerase activity in the control of antibiotic resistant Klebsiella pneumoniae biofilms. Sci Rep 13, 15188 (2023). https://doi.org/10.1038/s41598-023-42505-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-42505-3
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.